01 Access
Access
Our technology partner's Industrial-Scale Microbiome Mining (ISMM) harvests and concentrates natural microbial communities at kilogram-to-ton scale. That scale can surface rare, low-abundance small molecules that standard culturing or small-sample methods often miss.
02 Read
Read AI
Each harvest is profiled with deep analytical chemistry (LC-MS/MS), genomic, habitat, and biological-activity data. Together these form training sets for ApaisBio's AI models, which are designed to connect chemistry to biology.
03 Prioritize
Prioritize AI
ApaisBio's AI-coordinated discovery ranks candidates by biology, novelty, and feasibility, using spectral matching, clustering of unknown molecules, structure prediction from analytical data, and activity and target hypotheses, and building on our technology partner's analytics.
04 Design
Design AI
AI in-silico screening and AI-assisted medicinal chemistry explore derivatives and analogs designed for the properties a gut-restricted oral drug needs, such as stability in the stomach and staying in the gut. Early AI-driven liability and ADME/tox triage is designed to flag risks before anything is synthesized.
05 Validate
Validate AI
Only top candidates move into the lab: wet-lab confirmation, safety screens, and animal studies, each set up as a go/no-go gate. Results feed back into our AI models to guide the next round of optimization. If a program doesn't clear a gate, we stop or redesign rather than spend more.